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Quality controlOne of the critical problems with the combustion of sugar and fat is the generation of cellular oxidation. The
ongoing consumption of oxygen results in damage to lipids, protein andmtDNA,whichmust be repaired through
essential pathways inmitochondrial quality control. It has long been established that intrinsic protease pathways
within the matrix and intermembrane space actively degrade unfolded and oxidized mitochondrial proteins.
However, more recent work into the ﬁeld of quality control has established distinct roles for bothmitochondrial
fragmentation and hyperfusion in different aspects of quality control and survival. In addition, mitochondrial de-
rived vesicles have recently been shown to carry cargo directly to the lysosome, adding further insight into the
integration of mitochondrial dynamics in cellular homeostasis. This review will focus on the mechanisms and
emerging questions concerning the links between mitochondrial dynamics and quality control. This article is
part of a Special Issue entitled: Protein Import and Quality Control in Mitochondria and Plastids.
© 2012 Elsevier B.V. All rights reserved.1. Introduction: Mitochondrial proteases and the ﬁrst line of defense
The question of mitochondrial quality control was ﬁrst addressed
with the discovery of a series ofmitochondrial proteases thatwere evo-
lutionarily conserved from bacteria. The matrix localized Lon protease
has its origins in bacterial quality control pathways [1]. In mammalian
cells, the AAA protease Lon has been shown to recognize oxidized
cargo like aconitase [2], but it also can regulate mtDNA levels either di-
rectly [3], or through the degradation of the mitochondrial nucleoid-
associated transcription factor A, TFAM, indirectly regulating mtDNA
copy number [4]. As in bacteria, the regulation of protein turnover in
themitochondria is also subject by the “N-end rule”, where the stability
of the protein is dependent upon the N-terminal exposed residue. Pro-
tein stability of imported proteins can be tightly regulated through a
second cleavage event mediated by matrix intermediate proteases.
This cleavage has been shown to remove unstable N-terminal residues,
effectively stabilizing the protein [5,6]. The N-terminal residues ofmito-
chondrial proteins are therefore critical determinants of the half-life of a
broad spectrum of proteins.Import and Quality Control in
titute, McGill University, 3801
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ide).
rights reserved.The importance ofmitochondrial proteases in quality control has been
demonstrated by the direct links to human diseaseswhere AAAproteases
are mutated. These include the inner membrane anchored AAA protease
complex, AFG3L2 and Spg7, both of which have been linked to familial
forms of human spastic paraplegia and ataxia [7–9]. The function of
these proteases is broad, as they often have roles in import and processing
of substrates, as well as inmitochondrial dynamics through the regulated
cleavage of substrates like the innermembrane fusionGTPaseOpa1. Opa1
is highly complex; with 8 splice variants, and at least two different cleav-
age sites. Some splice variants are cleaved constitutively by the inter-
membrane space protease Yme1 [10,11], but it was also shown that
AFG3L2 participates in the regulation of Opa1 cleavage events, contribut-
ing to the balance of long- and short-forms of the GTPase in steady state
[12]. Furthermore, upon the loss of mitochondrial electrochemical poten-
tial, another innermembrane protease Oma1, cleaves all of the Opa1 var-
iants to the short form, effectively blocking mitochondrial fusion [12,13].
Opa1 has been a particularly complicated substrate, with many different
mitochondrial proteases acting upon it, depending on the situation. For
example, one of the Opa1 proteases, the rhomboid protein PARL [14], reg-
ulates mitochondrial dynamics through a conserved N-terminal matrix
domain, which is subject to proteolytic cleavage in a manner dependent
upon the phosphorylation state [15,16]. Importantly, PARL has also been
identiﬁed as a Parkinson's disease gene, further implicatingmitochondrial
proteases in human disease [17]. The use of complex protease cascades in
the regulation of protein turnover and function has become a recurrent
theme, placing the mechanisms for protease regulation as a critical
focus for future research.
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A young graduate student named Derek Narendra in the lab of
Richard Youle did an experiment that changed the ﬁeld almost over-
night. He simply added a mitochondrial poison, CCCP, which depolar-
izes the electrochemical potential across the mitochondrial inner
membrane [18]. Over the course of an hour, Derek observed an almost
complete recruitment of a ubiquitin E3 ligase called Parkin to the
uncoupled and fragmented mitochondria. The continued treatment
of the cells with CCCP eventually led to the clearance of all of the
mitochondria through the autophagic pathway. If ever there was an
Archimedes-inspired “Eureka!” moment in mitochondrial quality
control, this was it. Neuroscientists had been intensely investigating
Parkin, which ismutated in some forms of familial Parkinson's disease,
for over a decade. They had established that the loss of Parkin led to
mitochondrial dysfunction in Drosophila Melanogaster [19–21], yet
the mechanistic links to mitochondria remained elusive. Since the
publication of this result in 2008, there has been an exponential rise
in publications focused on the role of Parkin and other PD related
genes in mitochondrial quality control.
Importantly, parkin mediated mitophagy required that the mito-
chondria be fragmented, since the loss of mitochondrial ﬁssion blocked
the clearance of the organelles [22]. The recognition of dysfunctional
fragments by Parkin is essential in this pathway, as fragmentation
alone does not trigger mitophagy [23]. In this way, we learned an im-
portant new function for mitochondrial ﬁssion — to allow for the re-
moval of damaged organelles. It had been shown a few months before
the Narendra study that mitochondrial depolarization occurred during
a ﬁssion event, and this may function to continually “survey” the retic-
ulum for the ability to recover from transient depolarization [24]. How-
ever, the delivery of the depolarized organelle to the autophagosome
required a number of hours, so why don't they re-fuse with healthymi-
tochondria in the interim? As mentioned above, the loss of electro-
chemical potential leads to the activation of the inner membrane
protease Oma1, which cleaves the inner membrane fusion GTPase
Opa1 [10–13,25]. Once cleaved to the shorter form, Opa1 was released
from the inner membrane, and fusion was blocked. In this way the
lone, depolarized organelle becomes excommunicated from the reticu-
lum awaiting the recruitment of parkin and ﬁnal delivery to the cellular
gallows.
We have since learned that additional PD related genes, including
the kinase Pink1, are requisite for Parkin recruitment to depolarized
mitochondria [22,26–29]. In addition, depolarized organelles recruit
the chaperone p97/VCP, which facilitates the extraction and degrada-
tion of outer membrane proteins by the proteasome [30,31]. Togeth-
er, these data provide links between mitophagy and the proteasome,
suggesting that the removal of outer membrane proteins is requisite
for the recognition of the fragment by the autophagosome. In addi-
tion, it was discovered that p97/VCP/Cdc48 are speciﬁcally recruited
to mitochondria via the adaptor Vms1 in cells experiencing oxidative
stress in multiple organisms [32]. The mechanism of retrotransloca-
tion of mitochondrial proteins across the outer membrane to the
proteasome is not yet established, but is known to regulate the turnover
of many mitochondrial proteins [33–36]. With this, it is clear that
ubiquitin-mediated protein degradation occurs in the absence of
mitophagy as a mechanism for regulated mitochondrial protein turn-
over and quality control.
The established paradigm has been developed primarily using cul-
tured cells. The best example of mitophagy within physiology is the
example of the red cell. In this cell type, an outer membrane protein
Nix (Nip3 like protein X) plays a critical role in the clearance of all
mitochondria during development [37,38]. In this developmental
system, the clearance of mitochondria is not precipitated by their dys-
function or loss of potential. Nix functions directly as an adaptor to
couple the mitochondria to the autophagic proteins LC3 and
GABARAP, leading to the engulfment of mitochondria by theautophagosome in a developmentally regulated manner [39,40].
Studies in this model system have also shown roles for Parkin [41],
the outer membrane kinase Ulk1, and the cytosolic chaperones
Hsp90 and Cdc37 [42]. In another tissue-speciﬁc model of autophagy
within the heart, the Nix-related protein Bnip3 (Bcl2/E1B 19 kDa-
interacting protein 3-like protein) was shown to be requisite for
mitophagy in a mechanism that also requires mitochondrial ﬁssion
and parkin recruitment [43]. From all these studies, it appears that
two distinct steps must occur to facilitate mitophagy; the activation
of the autophagic machineries, and the selection of the dysfunctional
mitochondria, [41,44,45]. There is a growing complexity in the sig-
nals, adaptors and regulation of mitophagy that are currently under
investigation [46].
In skeletal muscle, the regulated cellular program ofmuscle atrophy
also requires active mitophagy [47]. In that study, mitochondrial ﬁssion
was required in order to activate transcription of at least two genes
encoding ubiquitin ligases required for atrophy-induced protein degra-
dation, Atrogen-1 andMURF-1 [47]. This demonstrates that the process
of mitophagy may also play a signaling role in determining cell fate in
addition to the clearance of dysfunctional organelles.
The loss of electrochemical potential is a primary trigger for
mitophagy, yet it is not clear whether mitochondria signiﬁcantly depo-
larize on a regular basis in vivo. In primary neurons, CCCP does not
necessarily lead to global uncoupling of mitochondria. A recent study
showed a differential effect depending on the carbon source provided
to the cells [48]. When cells were grown on glucose, CCCP depolarized
and parkin was recruited, however when grown on galactose which
drivesmitochondrial respiration, the drug did not lead to parkin recruit-
ment. This is becausemitochondria have evolvedmechanisms to ensure
they remain polarized in cells that require their services. For example,
the addition of oligomycin to these galactose treated cells reverted the
phenotype, and parkin was again recruited [48]. Oligomycin blocks
the ATP synthase (complex V), which had been running in reverse to
hydrolyze ATP, pumping protons back out of the matrix to regenerate
the electrochemical potential. More recent work has conﬁrmed the
relative resistance of neuronal mitochondria to depolarization, but
demonstrated a direct functional role for parkin recruitment in the neu-
ronal survival [49]. Rather than the rapid parkin recruitment in trans-
formed cells, it took 12–24 h before Parkin recruitment was observed
in only 5–30% of neurons. This work demonstrates the universality of
the paradigm. Future work will continue to focus on establishing the
molecular details of parkin recruitment to depolarized mitochondria.
3. Mitochondrial fusion as cellular stress response
Equally exciting has been the realization that themitochondria band
together in times of stress (Fig. 1). In a term coined by Daniel Tondera in
the lab of Jean-Claude Martinou, stress induced mitochondrial hyper-
fusion (SIHM)was observed in the hours following a number of cellular
stresses [50]. Prolonged stress ultimately leads to mitochondrial frag-
mentation, due to accumulated damage and depolarization. Whether
or not the fragmented mitochondria trigger apoptosis would depend
on the extent and duration of the stress trigger. Once fragmented, dys-
functional organelles may be cleared through mitophagy, potentially
restoring the reticulum to the normal state (see model, Fig. 1).
In the initial study, a prohibitin related protein Slp-2 was identiﬁed
as requisite for the hyperfusion response, and its presence ensured
the stability of Opa1 against stress-induced cleavage and degradation
[50]. Although the precise mechanisms of Opa1 protection by Slp2 re-
main unclear, the data support the idea that the architecture of the
inner membrane is likely very dynamic, responding to stress cues in
various ways. The cristae themselves are tightly controlled through a
conserved protein complex, recently named the MINOS (mitochondrial
inner membrane organizing system), mitOS (mitochondrial organizing
structure) or MICOS (mitochondrial contact site) complex present in
yeast, Caenorhabditis elegans and mammalian cells [51–58]. This
Fig. 1.Working hypothesis: mitochondrial hyperfusion as a stress response. Mitochondria containing green and red nucleoids are shown in the normal state. Green nucleoids con-
tain wild type mtDNA, and the red indicates a heteroplasmic or mutant mtDNA. Upon dysfunction, the organelles containing the mutant genomes may lose potential and become
degraded through mitophagy. Upon cellular stress or starvation, the mitochondria undergo hyperfusion. It has been shown that Drp1 becomes hyperphosphorylated and
inactivated by PKA during starvation, although this has not yet been demonstrated speciﬁcally for all stressors. Slp2 protects Opa1 from cleavage and inactivation during stress,
and it is likely that the outer membrane fusion machinery becomes activated in some speciﬁc manner. Once in the hyperfused state, damage can accumulate, and we have observed
that mitochondrial derived vesicles (MDVs) are stimulated during oxidative stress, carrying mitochondrial proteins to the lysosome. The hyperfused reticulum protects the organ-
elles from mitophagy and the cell from cell death. Rescue from this state could occur through the activation of the master transcription factor Nrf2, which upregulates the expres-
sion of antioxidant proteins, or through the restoration of nutrients. High levels and/or duration of cellular stress would ultimately lead to mitochondrial dysfunction. This activates
the phosphatase calcineurin, which dephosphorylates Drp1 and activates mitochondrial ﬁssion. Should the electrochemical potential become compromised, Opa1 would be cleaved
and fusion arrested. Once in the fragmented state, death may follow, or the potential clearance of damaged organelles through parkin-mediated mitophagy could again restore the
reticulum. Mitochondrial fragmentation can also be triggered directly upon apoptotic signals. Upon Bax activation, mitochondrial fusion is arrested, Drp1 is recruited and the cristae
become remodeled. Together, this leads to cytochrome c release and the execution of the death program. See text for details.
419T.E. Shutt, H.M. McBride / Biochimica et Biophysica Acta 1833 (2013) 417–424complex comprises a series of proteins that facilitate both cristae as-
sembly and protein import. It has not been established how the
MINOS complexmay contribute to dynamic functional changes inmito-
chondrial shape and activity during cellular stress. Both Opa1 and the
yeast orthologue Mgm1 are known to regulate cristae junctions
[59,60], so it is likely that the oligomerization of these GTPases may
play a critical role in the regulation of theMINOS complex. For example,
loss of Opa1 oligomers occurs during apoptosis, releasing the cristae
junctions to facilitate the exit of intermembrane space proteins
[59,61]. The involvement of the MINOS complex in these activities,
and potential links to the regulation of inner membrane fusion will cer-
tainly be the subject of future work.
Hyperfusion must require the speciﬁc activation of the fusion ma-
chinery, however it is not yet known how this might occur. The outer
membrane fusion GTPases Mfn1 andMfn2, have not been shown to be-
come post-translationally modiﬁed upon stress. They are ubiquitinated
by both MarchV/MITOL [62–65] and by Parkin [29–31,66,67], however
these conjugates are responsible for their downregulation and degrada-
tion by the proteasome, which is not consistent with a pro-fusion func-
tion. Another mitochondrial E3 ligase MAPL/MULAN demonstrates
inefﬁcient ubiquitination activity in vitro [68,69], however biochemical
and functional experiments suggest a primary role in the SUMOylation
of mitochondrial substrates, including Drp1 [69]. Ectopic MAPL expres-
sion promotes mitochondrial fragmentation and inhibits fusion [69,70],
making it an unlikely candidate in the activation of the mitofusins.Nevertheless, it is likely that themitofusinswill be activated through
stress induced post-translational modiﬁcations that are yet to be de-
ﬁned. Work in yeast models has demonstrated that Fzo1 may be
ubiquitinated during mitochondrial fusion [71,72]. These two laborato-
ries have shown that the Skp/cullin ubiquitin E3 ligase Mdm30 ubiqui-
tinates Fzo1 after GTP hydrolysis occurs. Using a series of tethering
assays, biochemical and genetic studies, it appears that Fzo1 undergoes
GTP hydrolysis upon mitochondrial docking, and this leads to its
ubiquitination and cleavage by the proteasome. TheMdm30 orthologue
has not been identiﬁed in mammalian systems, and ongoing work
continues to explore these possibilities. Finally, mitochondria cannot
fuse unless they are moved into close proximity. Links between Mfn2
and the Milton/Miro complex that regulates mitochondrial movement
on microtubules also suggest that the activation of motility and fusion
may be molecularly coupled as well [73]. At the mechanistic level,
there is still a great deal to learn about how the fusion process is
regulated.
Mitochondrial hyperfusion can also occur through the global inac-
tivation of the mitochondrial ﬁssion machinery. The recruitment of
the dynamin related protein Drp1 to the mitochondria is regulated
by a series of post-translational modiﬁcations including phosphoryla-
tion, sumoylation and ubiquitination [74]. The best characterized
among these is the role of phosphorylation, particularly in the regula-
tion of Drp1 recruitment during cellular stress. Recent work in two in-
dependent labs has elegantly shown that the activation of Protein
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and inactivation of Drp1 [75,76]. This led to an increase in mitochon-
drial interconnectivity in both cultured cells, and within the muscles
of mouse models. Although the process of hyperfusion obviously re-
quired the fusion machinery, it was not clear whether this machinery
was actively stimulated, or whether fusion resulted due to the ongo-
ing basal fusion activity in starved cells. It has been shown using a
cell-free fusion assay that addition of cytosols isolated from forskolin-
treated cells led to a two-fold increase inmitochondrial fusion over con-
trol [77]. This suggests that in addition to the arrest in mitochondrial
ﬁssion, the activation of PKA by forskolin also stimulates the fusion pro-
cess. However, it is not yet known what the molecular basis of this
stimulation was.
A fused mitochondrial reticulum has also been associated with
two other aspects of cellular physiology, the cell cycle and senescence.
Mitochondrial hyperfusion has been observed at G1S and manipulation
ofmitochondrialmorphology has been shown to affect cell cycle progres-
sion [78]. The induction of a fused morphology triggers senescence-
associated changes, suggesting that mitochondrial morphology as a
whole is coupled to cell fate [79–81]. It is currently unknown whether
there are distinct or common mechanisms regulating the hyperfused
networks found in response to stress, starvation, cell cycle progression
or senescence. Although the initial signals likely differ, at some point
the mechanisms must converge to drive the fusion machinery.
4. Why mitochondria fuse?
What is the advantage of mitochondrial hyperfusion during stress
or starvation? There are several intuitive answers to this question.
First, it was established as early as 2001 that DRP1-deﬁcient cells con-
taining hyperfused mitochondria were resistant to apoptosis [82].
During the ensuing decade, it was revealed that the apoptotic cascade
includes both the activation of Drp1 andmitochondrial ﬁssion, as well
as the inhibition of mitochondrial fusion [83]. The intimate relation-
ship between the mitochondrial shape-shifting machinery and the
pro- and anti-apoptotic machinery has therefore been the subject of
intense investigation in many different model systems. In one of the
most robust examples, it was recently shown that Bax promotes fu-
sion within non-apoptotic cells, however upon Bax activation during
a death trigger, Bax then integrates into the membrane and fusion be-
comes arrested [84]. Thereforemaintaining a hyperfusedmitochondrial
reticulum may protect cells, at least transiently, from death during
stress. Indeed, during starvation, blocking the ability of mitochondria
to fuse led to cell death, strongly supporting this idea [75]. The timing
of the hyperfusion response may also be coupled to the transcriptional
response that accompanies cell stress signals. For example, during
oxidative stress, the transcription factor Nrf2 becomes stabilized, trans-
locates to the nucleus and acts as a master regulator of anti-oxidant
gene expression [85,86]. The expression of genes like superoxide dis-
mutase and glutathione-related protective enzymes then relieve the
damage signals, which may reverse the hyperfused phenotype. If the
transcriptional responsewere insufﬁcient, then thedamagewould accu-
mulate, ultimately leading tomitochondrial dysfunction and fragmenta-
tion (Fig. 1). For example, the phosphatase calcineurin has been shown
to become active once mitochondria become depolarized, which would
dephosphorylate and activate Drp1 and ﬁssion [87–90]. Therefore, the
hyperfused response provides a strategy to band together until help is
called. If left too long, time runs out and the program would move to-
wards fragmentation and cell death.
The second intuitive answer that was alluded to above, is that
hyperfusedmitochondria are resistant to mitophagy. Particularly dur-
ing starvation, banding together into an interconnected reticulum
would render them too large to engulf [91]. In a number of systems,
it has been shown that mitophagy was arrested in cells where mito-
chondrial ﬁssion was blocked [18,24,43]. This clearly indicated that
ﬁssion is requisite for mitophagy. As a common physiologicalresponse to stress, mitochondrial hyperfusion may have evolved, at
least in part, to evade the lysosome until nutrients are restored.
A third possibility to explain mitochondrial fusion is the concept of
content mixing to rescue, or buffer, the damage that would increase
during stress or starvation [92,93]. By sharing lipids, proteins, RNA,
and mtDNA, fusion can ensure an even distribution of functional com-
plexes throughout the reticulum. However, this may also have long-
term detrimental effects since mixing damaged components could
effectively “contaminate” the healthy organelles. In this case, a highly
efﬁcient process of fragmentation andmitophagywould be an essential
aspect of recovery from the hyperfused state.
Finally, hyperfused mitochondria may be more metabolically efﬁ-
cient. It was observed that the density of cristae per micron of mito-
chondria was greatly increased upon starvation-induced hyperfusion
[75]. Since the cristae house the respiratory machinery, it follows that
an increase in their numbers may provide an increased metabolic efﬁ-
ciency when resources are scarce. For all of these reasons (and likely
others we have not yet considered), hyperfusion appears to play a pro-
tective role in the early stages of cellular stress.
The fusion and ﬁssion machinery are highly conserved and ubiqui-
tously expressed, and there is almost no doubt that there is active mito-
chondrial dynamics within differentiated tissue in vivo. However it
must be noted that there is limited experimental evidence that has
quantiﬁed the extent of content mixing in any given tissue. We know
that starvation induces mitochondrial hyperfusion in mouse muscle in
vivo, as measured using ultrastructural analysis [75]. It is also clear
that the loss of fusionmachinery within adult tissue compromises func-
tion in a number of organs including heart [94,95], brain [96], skeletal
muscle [97] and the pancreatic islet cells [98]. However, a recent kidney
speciﬁc knock-out of Mfn2 revealed totally normal renal function,
unless the cells were exposed to metabolic stress [99]. This suggests
that fusion may not be critical for the development and steady state
functions of all differentiated cells. One caveat of the inducible and/or
tissue speciﬁc knock out models is that the fusion machinery plays
dual roles, where Opa1 (and the yeast Mgm1) also regulates cristae
morphology [59,60] and Mfn2 is required for ER/mitochondrial contact
sites [100]. Therefore the phenotypes that result from loss of these two
genes cannot be blamed solely on an inability of the mitochondria to
fuse. Indeed a new role is emerging for Mfn2 in regulating the ER stress
response in a number of different model systems [101,102]. Neverthe-
less, from all of the emerging data, wewould predict thatmitochondrial
fusion may not play a signiﬁcant role in steady-state quality control, in
fact fusion has been shown to exacerbate mitochondrial damage [24].
Instead, the primary role of fusion is likely in the survival of the cell
under various forms of stress. One of the future challenges in the ﬁeld
will be to quantitatively monitor mitochondrial dynamics in differenti-
ated tissue.
5. Avoiding heteroplasmy
It can be argued that the most important component of mitochon-
drial quality is the integrity of their genome. Since the mtDNA lacks ro-
bust repair mechanisms, they are highly prone to the accumulation of
mutations with age and accumulated dysfunction [103,104]. There is
no mechanism to selectively degrade mutant genomes, rather the idea
is that mitochondria containing dysfunctional products of the mutant
genomes would be recognized and removed through mitophagy. Con-
sistent with this, Parkin-mediatedmitophagy has been shown to rescue
heteroplasmy in some cultured model systems [105,106]. Another
protein Gimap3 (GTPase of immunity-associated protein 3) was also
shown to play a role in heteroplasmic segregation in leukocytes [107],
although the mechanisms are not yet clear.
Given the importance of mtDNA integrity, do mitochondrial
dynamics play any active role in controlling mtDNA distribution or
turnover? To date the links between mitochondrial nucleoids and
mitochondrial shape are mostly indirect. Interference with
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[97,108–111], indicating that mtDNA replication is coupled to mito-
chondrial dynamics. It has also been noted through quantitative con-
focal microscopy that nucleoids are present in every mitochondrion,
inferring a molecular mechanism to ensure their presence prior to a
ﬁssion event [110]. The nucleoids are attached to the mitochondrial
inner membrane which anchors them at speciﬁc sites [112,113].
Early studies in yeast suggested that Mmm1, an ER/mitochondrial en-
counter structure (ERMES) component, may somehow couple both
mitochondrial membranes, anchoring the mtDNA in the matrix, to cy-
tosolic actin [114–116]. The mammalian orthologues of these com-
plexes are not yet known, yet it is likely that structures like these
regulate the spatial distribution of nucleoids. Integration between
these complexes and the activation of mitochondrial fusion or ﬁssion
could provide a means to precisely control the fate of each nucleoid.
Recent data suggests that the inner membrane fusion GTPase Opa1
binds to mtDNA within the matrix, which couples the fusion machin-
ery directly to mtDNA [117].
The anchoring and placement of mtDNA along the inner membrane
suggest that the transcription and translation of the gene products also
occur very locally at sites of import. This allows the efﬁcient assembly of
the large protein complexes that contain proteins arriving from the
cytosol and the matrix side. Should mutations accumulate within an
individual nucleoid, then it is likely that a “patch” of dysfunctional com-
plexeswithin the innermembranemay result. When this “patch” even-
tually becomes segregated through steady-state ﬁssion events [24], its
dysfunction would be recognized by the mitophagy machinery. In this
way, coupling the nucleoids to the membrane ensures the generation
of distinct functional (or dysfunctional) domains along the bilayer
that may allow their efﬁcient recognition and removal when necessary.
As a relatively stable structure, the positioning of the nucleoids would
remain local even upon mitochondrial hyperfusion, limiting the spread
of heteroplasmic, mutant genomes throughout the reticulum.
6. Mitochondrial derived vesicles and quality control
We recently discovered that the mitochondria have retained an-
other feature common to their bacterial ancestors, the ability to re-
lease vesicles into the cytosol [118]. Bacterial shedding of vesicles
plays critical roles in numerous aspects of their lives, from quorum
sensing to the invasion of host cells [119]. The molecular mechanisms
and regulation of this process in bacteria is now under intense inves-
tigation as the impact of bacterial vesicles in infection has become
more apparent. Over the last few billion years, the mitochondria
have co-evolved with an endomembrane system that employs a high-
ly complex system ofmachinery to facilitate vesicle transport. Howev-
er, unlike endocytosis and the biosynthetic pathways, there was no
reason to believe that proteins would ﬂow between the mitochondria
and other organelles. Therefore it had never been considered that the
mitochondria may participate in these types of behaviors. This view
has now changed since we have shown that vesicle transport occurs
between the mitochondria and at least two intracellular destinations.
In the most intuitive example, we have shown that mitochondrial
proteins are delivered to the multivesicular body/late endosome for
degradation using a vesicular transport route [120]. We also demon-
strated a direct pathway between the mitochondria and peroxisomes
[70,121], although the functional signiﬁcance of this route is still
under investigation. Given that both the mitochondria and peroxi-
somes play roles in the beta-oxidation of fatty acids, this connection
may relate to the common regulation of fat catabolism.
There are a number of implications that arise from this ﬁnding.
First, the selection of mitochondrial proteins that are expelled from
the organelle must be regulated in a manner similar to the mecha-
nisms employed in other vesicular transport events. This means that
cargo binding machinery, pinchases, GTPases, etc. must function at
the mitochondria. It is clear that mitochondrial vesicles are generatedin the absence of the ﬁssion GTPase Drp1 [70,120,121], so there must
be an additional pinchase that functions in this pathway. Indeed, the
diameter of the yeast Dnm1p spirals has been shown to be 100 nm
[122], which is too large to constrict the small vesicles with a 20 nm
neck. We have identiﬁed the retromer complex as critical in the deliv-
ery of the mitochondrial SUMO E3 ligase MAPL/MULAN to the perox-
isome [121]. We must also identify the mechanisms used to target to
speciﬁc acceptor compartments, for example tethering factors that
can differentiate between the peroxisomes and late endosomes. It
will take a great deal of future study to dissect and characterize these
pathways.
The most urgent question is to understand the contribution of mi-
tochondrial derived vesicles (MDVs) to mitochondrial quality control.
Mitochondrial turnover utilizes at least 3 pathways, mitophagy, pro-
teases and the proteasome, so why bother with a vesicular transport
route as well? MDVs are released from intact, otherwise healthy mi-
tochondria, and provide a means to remove protein complexes and
lipids in a single structure [120]. MDVs also appear to function inde-
pendently from Atg5-dependent autophagy, which may be important
in conditions when the activation of autophagy machinery is detri-
mental to the cell. On the other hand, we cannot yet exclude that
MDVs are engaged during autophagic programs, as there may be inte-
gration among the quality control pathways.
We do not understand how proteins, complexes or lipids are se-
lected for this pathway, rather than engaging the proteasome or pro-
teases within the mitochondria. Vesicles can carry larger, membrane-
associated complexes, which may be more easily degraded en masse
in the lysosome, rather than ratcheting their subunits across a bilayer
one by one for proteolysis. In addition, partially disassembled com-
plexes may be dangerous since electron transport may become leaky
and disrupted. It is also important to consider the role for MDVs in the
degradation of oxidizedmitochondrial lipids. Lipid peroxidation accom-
panies respiration and can become acute during times of stress. The
remodeling of lipids like cardiolipin during stress has been studied ex-
tensively [123–125]. However, there is very little known about the turn-
over and degradation of mitochondrial lipids in steady state. We
consider that the removal of oxidized lipids may be a central compo-
nent of the MDV pathway, and we are working towards the reconstitu-
tion of MDV budding in vitro in order to better analyze the contents of
the vesicles.
When thinking of the potential mechanisms that may trigger cargo
incorporation, we look to the established mechanisms described for
bacterial membrane shedding. In these cases, the trigger for vesicle
formation is often a pH or other environmental change that induces
speciﬁc periplasmic cargo proteins to oligomerize and form channels
or aggregates within the outer membrane [119]. This generates curva-
ture from the inside of the bacteria, and as it grows, the media will
slough the vesicle off through shear forces. Clearly there are many dif-
ferences at play within the mitochondria, however it is possible that
protein and/or lipid oxidation could induce some level of aggregation
that may be an initial trigger for vesicle generation. These potential ag-
gregates would then need to signal the recruitment of cytosolic factors
that would complete the task of budding the vesicle.
Finally, does the existence ofMDVs help explain somependingques-
tions in the ﬁeld? One of the controversies is whether or not mitophagy
in yeast requires mitochondrial ﬁssion or Dnm1 [126–129]. Depending
on the triggers, it is possible that Dnm1-independent clearance of mito-
chondria could occur through MDVs. So far, it is not known whether
MDVs are generated from yeast mitochondria. Although our studies
show that MDV transport to the lysosome can occur in the absence of
the autophagy machinery, this does not exclude that MDVs may play a
role during autophagy. Therefore, future experiments may look at the
generation of cargo-selected vesicles during autophagy in yeast in
order to explain mitochondrial clearance in the absence of Dnm1.
The second controversy has been described above, which is the
question of the role of Parkin in mitophagy in vivo. It is unclear
422 T.E. Shutt, H.M. McBride / Biochimica et Biophysica Acta 1833 (2013) 417–424whether or not individual mitochondria lose potential within tissues.
For example, dopaminergic neurons lackingmitochondrial respiration
did not recruit Parkin to themitochondria, even though these neurons
died, resulting in amousemodel of Parkinson's disease [130]. One pos-
sibilitymay be thatMDVs play a signiﬁcant role in vivo to extract dam-
aged mitochondrial cargo from organelles that globally retain their
electrochemical potential. Again, the challenge is to ﬁndways to quan-
titatively determine the contribution of each of these pathways in mi-
tochondrial quality control.
7. Conclusions
The ﬁeld of mitochondrial dynamics has accelerated exponentially
with the realization thatmitochondrial dysfunctionmay bemore causal
to disease than previously thought. We have here discussed the links
between the Parkinson's disease genes and the mitochondria. This
emerging area of research has provided a compelling model to explain
how accumulated mitochondrial damage may ultimately kill dopami-
nergic neurons in Parkinson's patients. This review has also focused
on the new role of mitochondrial hyperfusion as a cellular stress re-
sponse. An inability to fuse during times of stress was shown to render
cells to be susceptible to death, consistent with the identiﬁcation of
mutations in the fusion machinery that lead to degenerative diseases.
We have yet to learn whether errors in MDV transport are linked to
human disease, as we must ﬁrst identify the critical components of
the pathway. However, it should be noted that one of the retromer sub-
units Vps35 was recently identiﬁed as a new Parkinson's disease gene
[131,132]. As a requisite player in MDV transport to the peroxisome,
perhaps this link is not coincidental. It is very likely that as the ﬁeld con-
tinues to progressmechanistically, wewill gain a clearer understanding
of how mitochondrial damage is controlled. When one considers the
high levels of respiration in so many tissues, it is no wonder that the
mechanisms that control oxidative damage are complex, and include
multiple layers of redundancy. The challenges remaining are to focus
on the development of tools to improve the efﬁciency of these quality
control pathways. Clearing the mitochondria of damage and mtDNA
heteroplasmy is an urgent goal as this will help us ﬁnd ways to reverse
the myriad of degenerative human conditions.References
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